Physician

James Phillip Reed, D.O.

According to 2025 Medicare claims, James Reed, D.O. (NPI: 1790719441) practices psychiatry in the Sierra Vista-Douglas, AZ market, with the plurality of this provider's patient population coming from Cochise, AZ. This provider's primary affiliated billing organization is SAN PEDRO HEALTH PLLC (NPI: 1245501188; TIN: 451634248) and primary practice location at 85635-4600.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 206 traditional Medicare patients, billed 2,227 HCPCS/CPT codes, and received $135,543 in Medicare payments. The top billing code was 90834 (Psychotherapy, 45 minutes). Part D data shows 2,733 prescription claims across 193 beneficiaries totaling $658,100 in drug costs, led by Ingrezza (Valbenazine Tosylate). Open Payments data shows 67 records totaling $1,445. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $54,405 to $135,543. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $224,434 to $658,100. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$68K$136K2015 Medicare payment: $54,405 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $32,383 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $55,515 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $67,353 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $77,093 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $76,118 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $108,237 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $124,067 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $99,886 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $135,543 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151571,005$54,405
2016122611$32,383
20171501,181$55,515
20181571,488$67,353
20191761,537$77,093
20201761,413$76,118
20211991,802$108,237
20222022,068$124,067
20231841,623$99,886
20242062,227$135,543

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$329K$658K2015 Drug cost: $224,434 (USD; Tot_Drug_Cst)2016 Drug cost: $280,720 (USD; Tot_Drug_Cst)2017 Drug cost: $211,195 (USD; Tot_Drug_Cst)2018 Drug cost: $157,916 (USD; Tot_Drug_Cst)2019 Drug cost: $162,159 (USD; Tot_Drug_Cst)2020 Drug cost: $246,533 (USD; Tot_Drug_Cst)2021 Drug cost: $372,588 (USD; Tot_Drug_Cst)2022 Drug cost: $531,871 (USD; Tot_Drug_Cst)2023 Drug cost: $574,838 (USD; Tot_Drug_Cst)2024 Drug cost: $658,100 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151282,247$224,434
20161272,213$280,720
20171382,382$211,195
20181432,305$157,916
20191432,502$162,159
20201552,535$246,533
20211762,672$372,588
20222002,459$531,871
20231792,415$574,838
20241932,733$658,100

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90834Psychotherapy, 45 minutes64743$77
90836Psychotherapy with evaluation and management visit, 45 minutes4167$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more76197$64
90833Psychotherapy with evaluation and management visit, 30 minutes140561$52
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more142523$40

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IngrezzaValbenazine Tosylate27810$209,146
AplenzinBupropion Hbr12360$69,120
CaplytaLumateperone Tosylate24840$44,002
TetrabenazineTetrabenazine12360$43,853
NuedextaDextromethorphan Hbr/Quinidine23690$38,338

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.67$1,445Alkermes, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Phillip Reed, D.O.?

Tedicare shows public-source Medicare data for James Phillip Reed, D.O. (NPI 1790719441), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Phillip Reed, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Phillip Reed, D.O.?

James Phillip Reed, D.O. is linked to SAN PEDRO HEALTH PLLC (billing NPI 1245501188) in the available physician profile data.

Does James Phillip Reed, D.O. have Open Payments data?

James Phillip Reed, D.O. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.